Previously, we demonstrated that more CD40 on the surface of B cells (as is the case for carriers of the RA risk allele) has increased activation of the classical NF-κB pathway (as measured by phosphorylation of NF-κB p65) in human B cells upon CD40L activation [23]. Here, NFKB1 is linked to rheumatoid arthritis.